#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the oral cavity Angiosarcoma recurrent Frontotemporal dementia Glioblastoma multiforme Chronic myeloid leukaemia Cholangiocarcinoma Eosinophilic oesophagitis Multifocal motor neuropathy Chronic lymphocytic leukaemia refractory Central nervous system neoplasm Ductal adenocarcinoma of pancreas Barth syndrome Bronchiectasis Myelodysplastic syndrome with excess blasts Piriformis syndrome More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Trials in Disease Immunodeficiency congenital – Basic Information Encephalitis autoimmune – Treatment Antisynthetase syndrome – Basic Information Noonan syndrome – Treatment Hyperoxaluria Sjogren’s syndrome – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Life with Disease Alexander disease – Diagnostics Niemann-Pick disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tafasitamab Dasatinib Teriflunomide Eptacog Beta (Activated) Hydroxyzine Hydrochloride Polydextrose Ambrisentan Rifapentine Vx-264 R3R01 Regn7075 Specific Nucleic Acid Sna-Ebv Azelastine Oxycodone Hydrochloride Lisaftoclax Datopotamab Deruxtecan ALLERGEN EXTRACTS Calcium Levofolinate Blomia Tropicalis Calcitriol More therapies…

    Learn about Your Condition

    Testicular leiomyosarcoma Mitral valve incompetence Hyperparathyroidism secondary Eosinophilic gastritis Laryngeal cancer stage I Angiosarcoma non-metastatic Macular telangiectasia Myotonia Proteinuria Thalassaemia alpha Micrographic skin surgery Hypophosphatasia Endocarditis bacterial Neuroendocrine carcinoma Bladder cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of Sodium Selenite Followed by Chemotherapy in Patients with Advanced Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • SODIUM SELENITE PENTAHYDRATE
    Sweden

  • Study of inavolisib and fulvestrant for patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • Fulvestrant
    • Inavolisib
    Belgium Spain

  • Exercise Program Study for Early Breast Cancer Patients Taking Aromatase Inhibitors With or Without CDK4/6 Inhibitors to Improve Quality of Life

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Goserelin
    • Letrozole
    Spain

  • Comparing 1-Minute and 5-Minute Poractant Alfa Treatment for Respiratory Distress Syndrome in Very Premature Babies Born Before 28 Weeks

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neonatal respiratory distress syndrome
    Investigated Drugs:
    • Poractant Alfa
    Austria

  • A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    Austria Belgium Denmark Estonia Finland Germany +8

  • Testing 18F-DPA-714 PET scan as a marker of brain inflammation in patients with autoimmune encephalitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Encephalitis autoimmune
    France
Previous Page
1 … 69 70 71 72 73 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!